Exploring the Potential of AI in Precision Medicine Market: Transforming Healthcare Delivery

1
MarketsandMarkets Presents
Artificial Intelligence (AI) in precision
medicine involves the use of genomic data of an
individual to develop personalized medicine.
Genomic data is being accumulated in significant
quantities, providing scientists the ability to
study how genetic factors, such as mutations lead
to diseases. AI, especially deep learning, can
capture patient data from electronic health
records, diagnostic imaging systems,
prescriptions, genomic profiles, insurance
records, and wearable devices. With this data, it
is possible to create treatment plans for
patients.
2
MarketsandMarkets Presents
Drivers Technological advancements in cancer
biology will drive the AI in precision medicine
market growth The technological developments
across cancer biologics is expected to drive the
growth of AI in precision medicine market over
the forecast period. The presence of AI based
computational tools along with availability of
large sets of human genome databases have
resulted into strong enhancements in the
precision medicines. Industry participants are
emphasizing on strategic partnership and
collaboration activities to accelerate
developments across cancer biology and develop
precision medicines in the market. Download PDF
Brochure https//www.marketsandmarkets.com/pdfdow
nloadNew.asp?id153786351
3
MarketsandMarkets Presents
Drivers Technological advancements in cancer
biology will drive the AI in precision medicine
market growth For instance, in June 2022, GE
Healthcare (US) announced strategic collaboration
with Minerva Imaging (Denmark) for the
advancements in the precision medicine for
oncology treatments. The partnership emphasizes
on leveraging the Radionuclide therapy, which is
a type of precision medicine in which a
radioactive substance is supervised across
bloodstream in order to target the cancer cells
and irradiate them without potential side effects
compared to traditional cancer therapies. Such
developments and partnership activities will fuel
the AI in precision medicine market growth over
the forecast timeframe.   
4
MarketsandMarkets Presents
Growth of the geriatric population across the
globe There has been a significant growth
observed in the geriatric population and it is
expected to continue in coming years. For
instance, according to the October 2022
statistics by World Health Organization (WHO),
one out of every 6 people in the world will be
aged over 60 years or over by 2030. Also, by
2050, the population of people aged 60 years and
older will be doubled, which is around 2.1
billion. The risks of infections across geriatric
population is more compared to the younger people
or population. This will increase the adoption of
AI-based precision medicines over the forecast
timeline.    Speak to Analyst _at_
https//www.marketsandmarkets.com/speaktoanalystNe
w.asp?id153786351
5
MarketsandMarkets Presents
Challenges High cost associated with the
precision medicines pose a major challenge The
research development costs incurred for the
AI-based precision medicine is on the higher side
in comparison to the traditional medicines. These
medicines are expensive to produce as they are
specifically designed for an individual patient
and not for the mass market. Adding to this,
significant threat to personal health data also
pose a challenge to the growth of AI in precision
medicine market.
6
MarketsandMarkets Presents
Key Players in the market BioXcel Therapeutics
Inc. (US), GE Healthcare (US), Insilico Medicine
(US), Intel Corporation (US), Microsoft (US),
Tempus (US), NVIDIA Corporation (US), Sanofi
(France), Sensely, Inc. (US), Zephyr AI (US) are
few key players in the AI in Precision Medicine
Market globally. Browse For More Details -
https//www.marketsandmarkets.com/Market-Reports/a
i-in-precision-medicine-market-153786351.html
7
MarketsandMarkets Presents
About MarketsandMarkets MarketsandMarkets is a
blue ocean alternative in growth consulting and
program management, leveraging a man-machine
offering to drive supernormal growth for
progressive organizations in the B2B space. We
have the widest lens on emerging technologies,
making us proficient in co-creating supernormal
growth for clients. The B2B economy is
witnessing the emergence of 25 trillion of new
revenue streams that are substituting existing
revenue streams in this decade alone. We work
with clients on growth programs, helping them
monetize this 25 trillion opportunity through
our service lines - TAM Expansion, Go-to-Market
(GTM) Strategy to Execution, Market Share Gain,
Account Enablement, and Thought Leadership
Marketing.
8
MarketsandMarkets Presents
Contact Mr. Aashish Mehra MarketsandMarkets
INC. 630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 Email
sales_at_marketsandmarkets.com Visit Our Website
https//www.marketsandmarkets.com